Worth Venture Partners, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 65 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,671,028
-12.6%
657,885
-35.7%
0.82%
-27.8%
Q4 2022$1,912,028
-23.3%
1,022,475
+5.4%
1.13%
-26.0%
Q3 2022$2,492,000
+5.3%
969,6980.0%1.53%
+9.7%
Q2 2022$2,366,000
+1.6%
969,698
+23.7%
1.39%
+29.4%
Q1 2022$2,328,000
-6.9%
783,731
+40.7%
1.08%
-13.2%
Q4 2021$2,500,000
+32.1%
556,832
+43.0%
1.24%
+45.4%
Q3 2021$1,893,000
+20.0%
389,440
+68.3%
0.85%
+45.1%
Q2 2021$1,578,000
+17.0%
231,372
+21.1%
0.59%
-10.2%
Q1 2021$1,349,000
+12.8%
191,0930.0%0.65%
-30.9%
Q4 2020$1,196,000
+28.2%
191,093
+10.8%
0.95%
+23.8%
Q3 2020$933,000
+15.8%
172,537
-0.9%
0.76%
+7.7%
Q1 2017$806,000
+848.2%
174,176
+1177.0%
0.71%
+688.9%
Q4 2016$85,00013,6400.09%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q1 2023.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders